{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:39:28Z","timestamp":1789025968081,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2017\/002047"],"award-info":[{"award-number":["EMR\/2017\/002047"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.exer.2021.108555","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T01:23:17Z","timestamp":1616894597000},"page":"108555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Astaxanthin mediated regulation of VEGF through HIF1\u03b1 and XBP1 signaling pathway: An insight from ARPE-19\u00a0cell and streptozotocin mediated diabetic rat model"],"prefix":"10.1016","volume":"206","author":[{"given":"Rajasekar","family":"Janani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani Elavarasan","family":"Anitha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madan Kumar","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peethambaran","family":"Divya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallikannan","family":"Baskaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108555_bib1","first-page":"762","volume":"vol. 85","author":"Ablonczy","year":"2007"},{"key":"10.1016\/j.exer.2021.108555_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy","volume":"118","author":"Adamis","year":"1994","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib3","first-page":"561","article-title":"VEGF localisation in diabetic retinopathy","volume":"82","author":"Boulton","year":"1998","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.exer.2021.108555_bib4","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3892\/ijmm.2016.2768","article-title":"High glucose-induced epithelial-mesenchymal transition contributes to the upregulation of fibrogenic factors in retinal pigment epithelial cells","volume":"38","author":"Che","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2021.108555_bib5","series-title":"The Lancet","first-page":"124","article-title":"Diabetic retinopathy","author":"Cheung","year":"2010"},{"key":"10.1016\/j.exer.2021.108555_bib6","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/eye.2009.108","article-title":"Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis?","volume":"23","author":"Curtis","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108555_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/jcp.25971","article-title":"NAP counteracts hyperglycemia\/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression","volume":"233","author":"D'Amico","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.exer.2021.108555_bib8","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1167\/iovs.15-18397","article-title":"Progressive early breakdown of retinal pigment epithelium function in hyperglycemic rats","volume":"57","author":"Desjardins","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108555_bib9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/md11030960","article-title":"Astaxanthin attenuates the apoptosis of retinal ganglion cells in db\/db mice by inhibition of oxidative stress","volume":"11","author":"Dong","year":"2013","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.exer.2021.108555_bib10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archopht.1996.01100140410008","article-title":"Correlation of vascular permeability factor\/vascular endothelial growth factor with extraretinal neovascularization in the rat","volume":"114","author":"Dorey","year":"2015","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1152\/ajpcell.00001.2016","article-title":"Regulation of Cell Signaling Pathways High glucose promotes the migration of retinal pigment epithelial cells through increased oxidative stress and PEDF expression","volume":"311","author":"Farnoodian","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.exer.2021.108555_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.exer.2021.108555_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bjo.2007.123125","article-title":"Hypoxia-inducible factor expression in human RPE cells","author":"Forooghian","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ophtha.2005.10.030","article-title":"Vitreous levels of pigment epithelium \u2013 derived factor and vascular endothelial growth factor Are related to diabetic macular edema","volume":"113","author":"Funatsu","year":"2006","journal-title":"Ophthalmol. Times"},{"key":"10.1016\/j.exer.2021.108555_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00417-004-0950-7","article-title":"Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients","volume":"243","author":"Funatsu","year":"2005","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0002-9394(82)90241-0","article-title":"A transmission and scanning electrom microscopic study of surgically excised preretinal membrane proliferations in Diabetes mellitus","volume":"94","author":"Hamilton","year":"1982","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bjo.78.3.219","article-title":"Cytokeratin-containing cells in proliferative diabetic retinopathy membranes","volume":"78","author":"Hiscott","year":"1994","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.126747","article-title":"Blood-retina barrier failure and vision loss in neuron-specific degeneration","volume":"4","author":"Ivanova","year":"2019","journal-title":"JCI insight"},{"key":"10.1016\/j.exer.2021.108555_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/jcbfm.2009.78","article-title":"Decursin inhibits VEGF-mediated inner blood \u2013 retinal barrier breakdown by suppression of VEGFR-2 activation","volume":"29","author":"Kim","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.exer.2021.108555_bib20","doi-asserted-by":"crossref","first-page":"5152","DOI":"10.1167\/iovs.07-0427","article-title":"Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats","volume":"48","author":"Kusari","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108555_bib21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.febslet.2009.04.007","article-title":"Endoplasmic reticulum stress is implicated in retinal inflammation and diabetic retinopathy","volume":"583","author":"Li","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exer.2021.108555_bib22","article-title":"Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells","author":"Li","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108555_bib23","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.ajpath.2012.12.020","article-title":"Targeting the IRE1 a\/XBP1 and ATF6 arms of the unfolded protein response enhances VEGF blockade to prevent retinal and choroidal neovascularization","volume":"182","author":"Liu","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2021.108555_bib24","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K","article-title":"Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy","volume":"13","author":"Miller","year":"1997","journal-title":"Diabetes Metab. Rev."},{"issue":"2","key":"10.1016\/j.exer.2021.108555_bib25","first-page":"88","article-title":"Resveratrol suppresses expression of VEGF by human retinal pigment epithelial cells: potential nutraceutical for age-related macular degeneration","volume":"5","author":"Nagineni","year":"2014","journal-title":"Aging Dis"},{"issue":"10","key":"10.1016\/j.exer.2021.108555_bib26","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1211\/jpp.60.10.0013","article-title":"Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo","volume":"60","author":"Nakajima","year":"2008","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.exer.2021.108555_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"issue":"4","key":"10.1016\/j.exer.2021.108555_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/exer.1996.0239","article-title":"Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates","volume":"64","author":"Ozaki","year":"1997","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108555_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/ijmm.2015.2202","article-title":"3 , 3 \u2019 -Diindolylmethane inhibits VEGF expression through the HIF-1 \u03b1 and NF- \u03ba B pathways in human retinal pigment epithelial cells under chemical hypoxic conditions","volume":"36","author":"Park","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.exer.2021.108555_bib30","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1007\/s00125-003-1177-6","article-title":"Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina","volume":"46","author":"Park","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2021.108555_bib31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bjo.80.3.241","article-title":"Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy","volume":"80","author":"Pe\u2019er","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108555_bib32","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","article-title":"Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization","volume":"92","author":"Pierce","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exer.2021.108555_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jnutbio.2019.04.006","article-title":"A critical review on anti-angiogenic property of phytochemicals","volume":"71","author":"Rajasekar","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.exer.2021.108555_bib34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1152\/ajpendo.00360.2018","article-title":"miRNA-451a regulates RPE function through promoting mitochondrial function in proliferative diabetic retinopathy","volume":"2","author":"Shao","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.exer.2021.108555_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jff.2017.01.023","article-title":"Lutein downregulates retinal vascular endothelial growth factor possibly via hypoxia inducible factor 1 alpha and X-box binding protein 1 expression in streptozotocin induced diabetic rats","volume":"31","author":"Sharavana","year":"2017","journal-title":"J. Funct. Foods"},{"issue":"3","key":"10.1016\/j.exer.2021.108555_bib36","first-page":"362","article-title":"Diabetes and retinal vascular dysfunction","volume":"9","author":"Shin","year":"2014","journal-title":"J. Ophthalmic Vis. Res."},{"key":"10.1016\/j.exer.2021.108555_bib37","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1161\/CIRCULATIONAHA.113.002336","article-title":"Vascular endothelial growth factor and angiogenesis: the Xbp1 games","volume":"127","author":"Silvestre","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2021.108555_bib38","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1007\/s00125-008-0989-9","article-title":"Intravitreous anti-VEGF for diabetic retinopathy\u00a0: hopes and fears for a new therapeutic strategy","volume":"51","author":"Sim\u00f3","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.exer.2021.108555_bib39","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/190724","article-title":"The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy","author":"Sim\u00f3","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.exer.2021.108555_bib40","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11892-014-0510-4","article-title":"Anti-VEGF therapy for diabetic macular edema","volume":"14","author":"Stewart","year":"2014","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.exer.2021.108555_bib41","series-title":"U.S. Pat. No. 5,527,533. Washington, DC U.S. Pat. Trademark off. 40","volume":"vol. 5","author":"Tso","year":"1996"},{"key":"10.1016\/j.exer.2021.108555_bib42","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1167\/iovs.14-15874","article-title":"Decorin prevents retinal pigment epithelial barrier breakdown under diabetic conditions by suppressing p38 MAPK activation","volume":"56","author":"Wang","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.exer.2021.108555_bib43","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ajo.2009.07.007","article-title":"Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy","volume":"148","author":"Wang","year":"2009","journal-title":"Am. J. Ophthalmol."},{"issue":"6","key":"10.1016\/j.exer.2021.108555_bib44","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4239\/wjd.v4.i6.290","article-title":"Classification of diabetic retinopathy and diabetic macular edema","volume":"4","author":"Wu","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.exer.2021.108555_bib45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s12177-011-9068-4","article-title":"RPE barrier breakdown in diabetic retinopathy\u00a0: seeing is believing","volume":"4","author":"Xu","year":"2011","journal-title":"J. Ocul. Biol. Dis. Inform."},{"key":"10.1016\/j.exer.2021.108555_bib46","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.10-6518","article-title":"Significance of outer blood-retina barrier breakdown in diabetes and ischemia","author":"Xu","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.exer.2021.108555_bib47","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1167\/iovs.08-2591","article-title":"Role of PI3K\/akt and MEK\/ERK in mediating hypoxia- induced expression of HIF-1\u03b1 and VEGF in laser- induced rat choroidal neovascularization","volume":"50","author":"Yang","year":"2009","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108555_bib48","article-title":"Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats","author":"Yeh","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108555_bib49","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.exer.2004.11.015","article-title":"Vascular endothelial growth factor expression and secretion by retinal pigment epithelial cells in high glucose and hypoxia is protein kinase C-dependent","volume":"80","author":"Young","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108555_bib50","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db07-0982","article-title":"Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:10:45Z","timestamp":1757999445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521001202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":50,"alternative-id":["S0014483521001202"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108555","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astaxanthin mediated regulation of VEGF through HIF1\u03b1 and XBP1 signaling pathway: An insight from ARPE-19\u00a0cell and streptozotocin mediated diabetic rat model","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108555","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108555"}}